SG47811A1 - Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3-'pyrrolidine]-1,2',3,5',(2H)-tetrones useful as aldose reductase inhibitors - Google Patents
Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3-'pyrrolidine]-1,2',3,5',(2H)-tetrones useful as aldose reductase inhibitorsInfo
- Publication number
- SG47811A1 SG47811A1 SG1996004512A SG1996004512A SG47811A1 SG 47811 A1 SG47811 A1 SG 47811A1 SG 1996004512 A SG1996004512 A SG 1996004512A SG 1996004512 A SG1996004512 A SG 1996004512A SG 47811 A1 SG47811 A1 SG 47811A1
- Authority
- SG
- Singapore
- Prior art keywords
- tetrones
- aminospiro
- isoquinoline
- pyrrolidine
- useful
- Prior art date
Links
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 title abstract 4
- 125000001118 alkylidene group Chemical group 0.000 title abstract 2
- 239000003288 aldose reductase inhibitor Substances 0.000 title 1
- 229940090865 aldose reductase inhibitors used in diabetes Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/596,889 US5068332A (en) | 1990-10-12 | 1990-10-12 | Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG47811A1 true SG47811A1 (en) | 1998-04-17 |
Family
ID=24389149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996004512A SG47811A1 (en) | 1990-10-12 | 1991-10-10 | Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3-'pyrrolidine]-1,2',3,5',(2H)-tetrones useful as aldose reductase inhibitors |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5068332A (de) |
| EP (1) | EP0555327B1 (de) |
| JP (1) | JP3115597B2 (de) |
| KR (1) | KR100212110B1 (de) |
| AT (1) | ATE175673T1 (de) |
| AU (1) | AU645866B2 (de) |
| CA (1) | CA2093793C (de) |
| DE (1) | DE69130771T2 (de) |
| DK (1) | DK0555327T3 (de) |
| ES (1) | ES2126577T3 (de) |
| GR (1) | GR3029883T3 (de) |
| LV (1) | LV12444B (de) |
| PT (1) | PT99185B (de) |
| SG (1) | SG47811A1 (de) |
| WO (1) | WO1992006974A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5102886A (en) * | 1990-10-12 | 1992-04-07 | American Home Products Corporation | 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors |
| US5189167A (en) * | 1991-11-25 | 1993-02-23 | American Home Products Corporation | Alkylidene analogs of 1'-amino-2-[(benzothiazolyl)-methyl]spiro [isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors |
| ES2101291T3 (es) * | 1991-11-25 | 1997-07-01 | American Home Prod | 1'-amino-2-((benzotiazolil)metil)espiro(isoquinolina-4(1h),3'-pirrolidina)-1,2',3,5'(2h)-tetronas y sus analogos utiles como inhibidores de aldosa reductasa. |
| DE69529056T2 (de) * | 1994-01-19 | 2003-11-13 | Sankyo Co., Ltd. | Pyrrolopyridazin-derivate |
| CA2685202C (en) * | 2007-03-23 | 2017-11-28 | The Board Of Regents Of The University Of Texas System | Methods for treating allergic asthma |
| JP4708469B2 (ja) | 2008-02-29 | 2011-06-22 | Tdk株式会社 | バルントランス |
| KR20220144510A (ko) * | 2021-04-20 | 2022-10-27 | 에스케이이노베이션 주식회사 | 신규한 디아자스피로 화합물 및 이의 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200642A (en) * | 1978-08-21 | 1980-04-29 | Pfizer Inc. | Spiro-oxazolidindiones |
| IE52879B1 (en) * | 1981-05-12 | 1988-03-30 | Ici Plc | Pharmaceutical spiro-hydantoin derivatives |
| US4575507A (en) * | 1985-05-29 | 1986-03-11 | Pfizer Inc. | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use |
| AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US4927831A (en) * | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US5045544A (en) * | 1990-05-21 | 1991-09-03 | American Home Products Corporation | N'-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
-
1990
- 1990-10-12 US US07/596,889 patent/US5068332A/en not_active Expired - Lifetime
-
1991
- 1991-10-09 PT PT99185A patent/PT99185B/pt not_active IP Right Cessation
- 1991-10-10 DE DE69130771T patent/DE69130771T2/de not_active Expired - Fee Related
- 1991-10-10 ES ES91919785T patent/ES2126577T3/es not_active Expired - Lifetime
- 1991-10-10 EP EP91919785A patent/EP0555327B1/de not_active Expired - Lifetime
- 1991-10-10 KR KR1019930701087A patent/KR100212110B1/ko not_active Expired - Fee Related
- 1991-10-10 AU AU89228/91A patent/AU645866B2/en not_active Ceased
- 1991-10-10 SG SG1996004512A patent/SG47811A1/en unknown
- 1991-10-10 DK DK91919785T patent/DK0555327T3/da active
- 1991-10-10 CA CA002093793A patent/CA2093793C/en not_active Expired - Fee Related
- 1991-10-10 WO PCT/US1991/007467 patent/WO1992006974A1/en not_active Ceased
- 1991-10-10 AT AT91919785T patent/ATE175673T1/de not_active IP Right Cessation
- 1991-10-10 JP JP03518067A patent/JP3115597B2/ja not_active Expired - Fee Related
-
1999
- 1999-04-05 GR GR990400972T patent/GR3029883T3/el unknown
-
2000
- 2000-01-11 LV LVP-00-04A patent/LV12444B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR930702347A (ko) | 1993-09-08 |
| HK1011356A1 (en) | 1999-07-09 |
| JPH06502169A (ja) | 1994-03-10 |
| WO1992006974A1 (en) | 1992-04-30 |
| ATE175673T1 (de) | 1999-01-15 |
| US5068332A (en) | 1991-11-26 |
| CA2093793A1 (en) | 1992-04-13 |
| PT99185B (pt) | 1999-04-30 |
| JP3115597B2 (ja) | 2000-12-11 |
| ES2126577T3 (es) | 1999-04-01 |
| LV12444A (en) | 2000-03-20 |
| AU645866B2 (en) | 1994-01-27 |
| LV12444B (en) | 2000-06-20 |
| EP0555327A1 (de) | 1993-08-18 |
| GR3029883T3 (en) | 1999-07-30 |
| AU8922891A (en) | 1992-05-20 |
| DE69130771D1 (de) | 1999-02-25 |
| DE69130771T2 (de) | 1999-05-27 |
| CA2093793C (en) | 2001-08-21 |
| DK0555327T3 (da) | 1999-08-30 |
| EP0555327B1 (de) | 1999-01-13 |
| PT99185A (pt) | 1992-09-30 |
| KR100212110B1 (ko) | 1999-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0180539B1 (en) | N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe-and phenethylamine derivatives | |
| TW369535B (en) | A pyrazolopyridine compound and the process for preparing thereof | |
| PL306084A1 (en) | Novel compound and method of obtaining them as well as pharmaceutic agent containing such compounds | |
| CA2173963A1 (en) | Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases | |
| HUT71548A (en) | Tricyclic benzazepine and benzazocine derivatives, pharmaceutical compositions of vasopressin antagonistic activity containing them and process for preparing said compounds | |
| IL127296A0 (en) | Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases | |
| CA2042113A1 (en) | Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors | |
| GR3029883T3 (en) | Alkylidene analogs of 1'-aminospiro-[isoquinoline- 4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors in vivo | |
| AU6690190A (en) | New thiophene derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them | |
| CA2093794A1 (en) | 1'-aminospiro¬isoquinoline-4(1h),3-pyrrolidine|-1,2',3,5'-(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors | |
| AU5608790A (en) | New pyrrolidone derivatives, the process for their preparation and the pharmaceutical compositions containing them | |
| IE781858L (en) | N-methylene thienamycin derivatives | |
| EP0276805A3 (en) | Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds | |
| EP1057829A4 (de) | Kondensierte Pyrimidinderivate und diese enthaltende pharmazeutische Zubereitungen | |
| CA2068590A1 (en) | Process and intermediates for the preparation of spiro¬isoquinoline-4(1h),3'-pyrrolidine|-1,2',3,5'(2h)-tetrones which are useful as aldose reductase inhibitors | |
| PY0101652A (es) | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors | |
| JP2025183301A (ja) | 抗マラリア薬 | |
| SG47554A1 (en) | 1'-amino-2-[(benzothiazolyl)methyl)]spiro [isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors | |
| ZA9010151B (en) | Imidazolyl propyl guanidine derivative,a process for its preparation and a pharmaceutical composition containing this compound | |
| IT1247921B (it) | Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |